• DEVENEZ MEMBRE
    Pour un accès complet à theheart.org
    À titre de membre permanent, vous pourrez accéder au contenu éditorial et de formation continue, utiliser le moteur de recherche, recevoir nos newsletters, participer aux discussions, télécharger des diapositives et plus encore.

    L'abonnement est gratuit !
    Inscrivez-vous maintenant !
    Obtenez un accès limité de 30 jours aux articles de heartwire
    Professionnel de la santé   Oui Non
    Obtenez un accès limité !

EuroHF 2011 - Gothenburg, Sweden

Heartwire

Heart failure
WHICH? trial: HF-nurse home visits cut in-hospital days vs clinic-based care
Jun 3, 2011 09:45 EDT
A home-based approach to the postdischarge care of patients with heart failure didn't improve survival or rehospitalization rates in the trial, compared with care at a specialty outpatient clinic, but maybe that shouldn't be the point of such a trial, according to researchers.
Heart failure
Omega-3 PUFAs don't protect against new AF in heart failure: GISSI-HF analysis
May 25, 2011 10:00 EDT
A gram a day of omega-3 polyunsaturated fatty acids didn't cut the risk of incident atrial fibrillation among the trial's patients who were AF-free at baseline; no subgroup showing a protective effect could be identified.
Heart failure
"How soon" might trump "how" for ADHF treatment, hints ASCEND-HF analysis
May 24, 2011 12:15 EDT
Why didn't nesiritide alleviate dyspnea better in the largest-ever randomized trial in acute decompensated heart failure? A post hoc analysis suggests that, just maybe, "time to treatment may be more important than the kind of therapy."
Heart failure
MitraClip: Clinical, functional gains in "high-surgical-risk" EVEREST-REALISM cohort
May 24, 2011 10:00 EDT
Chamber volumes and symptoms improved in patients with mitral regurgitation who were deemed too high risk for surgery but given the transcatheter implant. The benefits seemed more pronounced in the majority who had functional rather than degenerative mitral regurgitation.
Aldosterone antagonist in HF cuts risk of new atrial fib: EMPHASIS-HF analysis
Heart failure
Aldosterone antagonist in HF cuts risk of new atrial fib: EMPHASIS-HF analysis
2 COMMENTS - May 23, 2011 08:00 EDT
Not only was incident AF reduced in patients with mild heart failure randomized to receive eplerenone, the drug was just as clinically effective in those with and without the arrhythmia at baseline.
High heart rate: Culprit or bystander in heart failure?
Heart failure
High heart rate: Culprit or bystander in heart failure?
3 COMMENTS - May 22, 2011 14:03 EDT
A "debate" had much to teach about the physiology underlying the benefits of contemporary heart-failure therapy and what could be a new twist in managing patients with the disorder.

Discussion and opinions

Blogs
This week in cardiology from heartwire
#91: More controversy for ezetimibe; NIH stops AIM-HIGH; apixaban approved in Europe; DHA, EPA, and...
May 27, 2011 11:20 EDT